Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NEO – Neogenomics Inc.

NEO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

11.86

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.08

EPS Last/This Y

1.02

EPS This/Next Y

0.16

Price

16.57

Target Price

19.72

Analyst Recom

1.67

Performance Q

Upside

-184.5%

Beta

1.73

Ticker: NEO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13NEO14.110.070.8812456
2026-07-14NEO14.240.070.1712452
2026-07-15NEO14.490.070.0312460
2026-07-16NEO14.850.070.0412553
2026-07-17NEO14.60.060.2912688
2026-07-20NEO14.240.050.0412259
2026-07-21NEO14.440.050.0312176
2026-07-22NEO140.050.0412235
2026-07-23NEO14.250.050.0212235
2026-07-24NEO13.890.050.8712274
2026-07-27NEO13.140.050.2112232
2026-07-28NEO13.420.050.0012209
2026-07-29NEO15.290.050.0812243
2026-07-30NEO15.880.050.0512621
2026-07-31NEO15.280.050.2612833
2026-08-03NEO15.840.060.0012930
2026-08-04NEO16.280.050.0914629
2026-08-05NEO15.730.050.0714895
2026-08-06NEO15.560.050.0214933
2026-08-07NEO16.580.050.0214904
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13NEO14.1012.1- 0.18
2026-07-14NEO14.2512.1- 0.18
2026-07-15NEO14.4812.1- 0.18
2026-07-16NEO14.8512.1- 0.18
2026-07-17NEO14.6012.1- 0.18
2026-07-20NEO14.2412.1- 0.18
2026-07-21NEO14.4412.1- 0.18
2026-07-22NEO14.0112.1- 0.18
2026-07-23NEO14.2512.1- 0.18
2026-07-24NEO13.8912.1- 0.18
2026-07-27NEO13.1412.1- 0.18
2026-07-28NEO13.4012.1- 0.18
2026-07-29NEO15.3012.1- 0.18
2026-07-30NEO15.8812.1- 0.18
2026-07-31NEO15.2881.8- 0.18
2026-08-03NEO15.8481.8- 0.18
2026-08-04NEO15.8481.8- 0.18
2026-08-05NEO15.7378.8- 0.18
2026-08-06NEO15.5678.8- 0.18
2026-08-07NEO16.5778.8- 0.18
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13NEO-1.335.559.09
2026-07-14NEO-1.335.559.09
2026-07-15NEO-1.335.559.09
2026-07-16NEO-1.335.559.09
2026-07-17NEO-1.335.559.09
2026-07-20NEO-1.335.349.09
2026-07-21NEO-1.335.349.09
2026-07-22NEO-0.435.349.09
2026-07-23NEO-0.435.349.09
2026-07-24NEO-0.435.349.09
2026-07-27NEO-0.435.3310.77
2026-07-28NEO-0.435.3310.77
2026-07-29NEO-0.435.3310.77
2026-07-30NEO-0.435.3310.77
2026-07-31NEO-0.445.3310.92
2026-08-03NEO-0.443.2910.92
2026-08-04NEO-0.443.2911.86
2026-08-05NEO-0.093.2911.86
2026-08-06NEO-0.253.2911.86
2026-08-07NEO-0.253.2911.86
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-0.25

Institutional Transactions

3.29

Beta

1.73

Average Sales Estimate Current Quarter

205

Average Sales Estimate Next Quarter

209

Fair Value

Quality Score

45

Growth Score

48

Sentiment Score

95

Actual DrawDown %

69.7

Max Drawdown 5-Year %

-90.8

Target Price

19.72

P/E

Forward P/E

49

PEG

0.85

P/S

2.78

P/B

2.7

P/Free Cash Flow

EPS

-0.4

Average EPS Est. Cur. Y​

0.18

EPS Next Y. (Est.)

0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.77

Relative Volume

0.46

Return on Equity vs Sector %

-33.9

Return on Equity vs Industry %

-18.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NEO Healthcare
$16.57
📉
Swing / Pullback
Buy the dip on strong trends
52 /100
WEAK
Trend
20/20
Pullback
4/25
Volume
8/15
Valuation
9/20
TP/AR
3/10
Options
8/10
RSI
65.4
Range 1M
99%
Sup Dist
7.1%
🚀
Momentum Growth
Ride accelerating trends
55 /100
WATCH
Momentum
24/25
Growth
15/30
Estimates
4/20
Inst/Vol
4/15
Options
8/10
EPS Yr
52.3%
52W%
99.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -14.7% upside
Quality
6/30
Valuation
4/30
Growth
10/25
Stability
7/10
LT Trend
4/5
Upside
-14.7%
Quality
45
NEO — P/E HistoricalDiagnostics & Research
NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
NEO

Latest News

Caricamento notizie per NEO
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading

NEO – NeoGenomics, Inc.

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
NEO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

11.86

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.08

EPS Last/This Y

1.02

EPS This/Next Y

0.16

Price

16.57

Target Price

19.72

Analyst Recom

1.67

Performance Q

Upside

-184.5%

Beta

1.73

Ticker: NEO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13NEO14.110.070.8812456
2026-07-14NEO14.240.070.1712452
2026-07-15NEO14.490.070.0312460
2026-07-16NEO14.850.070.0412553
2026-07-17NEO14.60.060.2912688
2026-07-20NEO14.240.050.0412259
2026-07-21NEO14.440.050.0312176
2026-07-22NEO140.050.0412235
2026-07-23NEO14.250.050.0212235
2026-07-24NEO13.890.050.8712274
2026-07-27NEO13.140.050.2112232
2026-07-28NEO13.420.050.0012209
2026-07-29NEO15.290.050.0812243
2026-07-30NEO15.880.050.0512621
2026-07-31NEO15.280.050.2612833
2026-08-03NEO15.840.060.0012930
2026-08-04NEO16.280.050.0914629
2026-08-05NEO15.730.050.0714895
2026-08-06NEO15.560.050.0214933
2026-08-07NEO16.580.050.0214904
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13NEO14.1012.1- 0.18
2026-07-14NEO14.2512.1- 0.18
2026-07-15NEO14.4812.1- 0.18
2026-07-16NEO14.8512.1- 0.18
2026-07-17NEO14.6012.1- 0.18
2026-07-20NEO14.2412.1- 0.18
2026-07-21NEO14.4412.1- 0.18
2026-07-22NEO14.0112.1- 0.18
2026-07-23NEO14.2512.1- 0.18
2026-07-24NEO13.8912.1- 0.18
2026-07-27NEO13.1412.1- 0.18
2026-07-28NEO13.4012.1- 0.18
2026-07-29NEO15.3012.1- 0.18
2026-07-30NEO15.8812.1- 0.18
2026-07-31NEO15.2881.8- 0.18
2026-08-03NEO15.8481.8- 0.18
2026-08-04NEO15.8481.8- 0.18
2026-08-05NEO15.7378.8- 0.18
2026-08-06NEO15.5678.8- 0.18
2026-08-07NEO16.5778.8- 0.18
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13NEO-1.335.559.09
2026-07-14NEO-1.335.559.09
2026-07-15NEO-1.335.559.09
2026-07-16NEO-1.335.559.09
2026-07-17NEO-1.335.559.09
2026-07-20NEO-1.335.349.09
2026-07-21NEO-1.335.349.09
2026-07-22NEO-0.435.349.09
2026-07-23NEO-0.435.349.09
2026-07-24NEO-0.435.349.09
2026-07-27NEO-0.435.3310.77
2026-07-28NEO-0.435.3310.77
2026-07-29NEO-0.435.3310.77
2026-07-30NEO-0.435.3310.77
2026-07-31NEO-0.445.3310.92
2026-08-03NEO-0.443.2910.92
2026-08-04NEO-0.443.2911.86
2026-08-05NEO-0.093.2911.86
2026-08-06NEO-0.253.2911.86
2026-08-07NEO-0.253.2911.86
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-0.25

Institutional Transactions

3.29

Beta

1.73

Average Sales Estimate Current Quarter

205

Average Sales Estimate Next Quarter

209

Fair Value

Quality Score

45

Growth Score

48

Sentiment Score

95

Actual DrawDown %

69.7

Max Drawdown 5-Year %

-90.8

Target Price

19.72

P/E

Forward P/E

49

PEG

0.85

P/S

2.78

P/B

2.7

P/Free Cash Flow

EPS

-0.4

Average EPS Est. Cur. Y​

0.18

EPS Next Y. (Est.)

0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.77

Relative Volume

0.46

Return on Equity vs Sector %

-33.9

Return on Equity vs Industry %

-18.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]
NEO Healthcare
$16.57
📉
Swing / Pullback
Buy the dip on strong trends
52 /100
WEAK
Trend
20/20
Pullback
4/25
Volume
8/15
Valuation
9/20
TP/AR
3/10
Options
8/10
RSI
65.4
Range 1M
99%
Sup Dist
7.1%
🚀
Momentum Growth
Ride accelerating trends
55 /100
WATCH
Momentum
24/25
Growth
15/30
Estimates
4/20
Inst/Vol
4/15
Options
8/10
EPS Yr
52.3%
52W%
99.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -14.7% upside
Quality
6/30
Valuation
4/30
Growth
10/25
Stability
7/10
LT Trend
4/5
Upside
-14.7%
Quality
45
NEO — P/E HistoricalDiagnostics & Research
NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
[News_NEO _Stock]
stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today
news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance
stock history NEO – NeoGenomics, Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading